Risk, returns & timeframes illustration
1 min read
February 13, 2023
by
Belinda Nash

Inflation breaking hearts? šŸ’”

Is inflation breaking hearts this Valentine’s Day? Kiwis and Americans are cutting costs on love this year, but more than half of one generation plan to spend more. But with choccie and dinner out costing more, where will cupid’s arrow land?
1 min read
February 13, 2023
by
Belinda Nash

Inflation breaking hearts? šŸ’”

Is inflation breaking hearts this Valentine’s Day? Kiwis and Americans are cutting costs on love this year, but more than half of one generation plan to spend more. But with choccie and dinner out costing more, where will cupid’s arrow land?
1 min read
February 13, 2023
by
Belinda Nash

Inflation breaking hearts? šŸ’”

Is inflation breaking hearts this Valentine’s Day? Kiwis and Americans are cutting costs on love this year, but more than half of one generation plan to spend more. But with choccie and dinner out costing more, where will cupid’s arrow land?
Table of contents
Getting Started Investing course
Free Getting Started Course
Take your first, or next, step to becoming a confident investor with Hatch's free online course – just 10 minutes a day, for 10 days.

Couples may be more boring than their single mates, but even go-it-aloners with only this to look forward to on Valentine’s Day might be breaking retailers’ hearts. šŸ’” According to Trustpilot, inflation could be trying to break up the 2023 love story. They asked Americans whether they’ll spend on romance this year and 41% said ā€˜love isn’t in the budget’ at all this V-Day, with 23% ā€˜on the fence’. Of those whipping out the wallet, 66% plan to spend less. And only a quarter of Kiwis are saying it with flowers this year. šŸ„€

Forbes painted a slightly rosier picture with plenty planning a Valentine’s flex. šŸ˜ Forty percent say they’ll spend more than last year, with Gen Zers and Millennials the most generous at 59% and 44% respectively. Perhaps not surprising with younger people embracing buy now pay later (BNPL) to treat partners (which comes with its own red flags 🚩🚩🚩).

It may be heartbreaking news for those looking for a Hershey’s (HSY) kiss, however. šŸ’‹ According to The Balance, choccie treats cost 12% more today than last Valentine’s Day. Fancy dinner dates may be off the menu too. Increased labour and ingredient costs has hiked the price of eating out, typically 8.2% more than a year ago. And while they’re popular dining options amid recessionary fears, fast food dates at McDonalds (MCD) and Taco Bell (YUM) might be a fast-track to singledom for wannabe cupids. 🌮

It could be good news for 1-800-Flowers.Com (FLWS) though, with the cost of a dozen red roses in the US down a surprising 5% on last year. 🌹 And Victoria's Secret (VSCO) Galentine’s inclusive body campaign may be as much a hit with shoppers as it’s been for investors, who’ve seen share values increase 26.6% this year (YTD).

Warner Bros (WBD) may want daters to pony up for Magic Mike’s Last Dance to bump up their US$8.2 million slow Super Bowl Weekend takings. And the world’s largest diamond jewellery retailer, Signet Jewelers (SIG), which has seen revenues up 33% from pre-pandemic levels and tripled profitability, may be hoping for a bumper night of people popping the question. šŸ’Ā 

For Kiwis battening down the hatches, however, perhaps the most generous way to show love this year might be buying a dozen eggs? 🄚

ā€

Belinda Nash
Finance writer
•
Linkedin

We’re not financial advisors and Hatch news is for your information only. However dazzling our writing, none of it is a recommendation to invest in any of the companies or funds mentioned. If you want support before making any investment decisions, consider seeking financial advice from a licensed provider. We’ve done our best to ensure all information is current when we pushed ā€˜publish’ on this article. And of course, with investing, your money isn’t guaranteed to grow and there’s always a risk you might lose money.

Join the Kiwis who are hatching their tomorrow and have invested more than $1 billion with Hatch.

Explore another series
Tax
Money
Economy
Investing

More recent news articles

Recent learn articles

7 min read
Apr 15, 2025

EV market rising but Tesla sales decline

Predicted by some to become a US $1.58 trillion dollar market globally, in the US alone EV sales are up 11.4% year-over-year. Which countries are leading the fast-charge? And how could trade tariffs impact sales as we accelerate into the second quarter?
Read more
8 min read
Mar 25, 2025

What’s driving gold prices to record highs?

As the world waits for Trump’s tariffs policies to take effect, the allure of gold has sent bullion, stocks and ETFs to glittering highs. But could gold’s volatility and the potential for the US to sell its gold reserves to buy bitcoin prime other global central banks to do the same?
Read more
8 min read
Mar 4, 2025

Can Biotech beat cancer?

Some Kiwi companies are making significant advances in cancer diagnosis and treatment that could save lives worldwide. Global pharmaceutical companies are also making huge strides in cancer clinical trials, but could Trump’s administration derail decades of research?
Read more

Related news articles

More recent learn articles

No items found.

Recent news articles

More recent learn articles

7 min read
Apr 15, 2025

EV market rising but Tesla sales decline

Predicted by some to become a US $1.58 trillion dollar market globally, in the US alone EV sales are up 11.4% year-over-year. Which countries are leading the fast-charge? And how could trade tariffs impact sales as we accelerate into the second quarter?
Read more
8 min read
Mar 25, 2025

What’s driving gold prices to record highs?

As the world waits for Trump’s tariffs policies to take effect, the allure of gold has sent bullion, stocks and ETFs to glittering highs. But could gold’s volatility and the potential for the US to sell its gold reserves to buy bitcoin prime other global central banks to do the same?
Read more
8 min read
Mar 4, 2025

Can Biotech beat cancer?

Some Kiwi companies are making significant advances in cancer diagnosis and treatment that could save lives worldwide. Global pharmaceutical companies are also making huge strides in cancer clinical trials, but could Trump’s administration derail decades of research?
Read more